Skip to main content
. 2023 Jun 28;14(7):1364. doi: 10.3390/genes14071364

Figure 2.

Figure 2

Biomarkers correlated with breast cancer subtypes and future perspectives. (I) Recent studies highlight new, and more predictive and accurate biomarkers that are capable of personalizing breast cancer treatment and diagnosis. Consequently, (II) there is a precise direction in terms of classification of classical breast cancer subtypes. Furthermore, new classifications become possible through single-cell strategies and analysis of PGCCs.